Search Results - "Coste, Gérard"

Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection by Mullins, Christopher, Eisen, Geoffrey, Popper, Stephen, Sarr, Abdoulaye Dieng, Sankalé, Jean-Louis, Berger, Judith J., Wright, Sharon B., Chang, Hernan R., Coste, Gérard, Cooley, Timothy P., Rice, Peter, Skolnik, Paul R., Sullivan, Margaret, Kanki, Phyllis J.

“…Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause AIDS, is endemic to West Africa but is infrequently found outside this…”
Get full text

Implementing Group Visits for Opioid Use Disorder: A Case Series by Sokol, Randi, Albanese, Mark, Albanese, Chiara, Coste, Gerard, Grossman, Ellie, Morrill, Diana, Roll, David, Sobieszczyk, Amy, Schuman-Olivier, Zev

“…Background: Group-based models of Office-Based Opioid Treatment with buprenorphine-naloxone (B/N) are increasingly being implemented in clinical practice to…”
Get full text

Fungemia Due to Hormonema dematioides Following Intense Avian Exposure by Kent, David, Wong, Tom, Osgood, Rebecca, Kosinski, Katharine, Coste, Gerard, Bor, David

“…Dematiaceous (pigmented) fungi are increasingly recognized as a cause of opportunistic infections in humans. Since Lagerberg first described Hormonema…”
Get full text

Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort by Peters, Vicki, Liu, Kai-Lih, Dominguez, Kenneth, Frederick, Toni, Melville, Sharon, Hsu, Ho-Wen, Ortiz, Idith, Rakusan, Tamara, Gill, Balwant, Thomas, Pauline

“…Despite dramatic reductions in perinatal human immunodeficiency virus (HIV) transmission in the United States, obstacles to perinatal HIV prevention that…”
Get full text

Implementing group visits for opioid use disorder: A case series by Sokol, Randi, Albanese, Mark, Albanese, Chiara, Coste, Gerard, Grossman, Ellie, Morrill, Diana, Roll, David, Sobieszczyk, Amy, Schuman-Olivier, Zev

“…Background: Group-based models of Office-Based Opioid Treatment with buprenorphine-naloxone (B/N) are increasingly being implemented in clinical practice to…”
Get full text